Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 54.99% is in line with its 5-year average of 53.14%, near the high end of its 5-year range (39.35%–55.13%).
As of the fiscal period ended Thursday, April 30, 2026. 4.18% above its 12-month average of 52.78%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
54.99%
GROSS MARGIN AVG TTM
52.78%
GROSS MARGIN AVG 3Y
53.55%
GROSS MARGIN AVG 5Y
54.05%
GROSS MARGIN AVG 10Y
53.79%
GROSS MARGIN AVG 15Y
53.12%
GROSS MARGIN AVG 20Y
53.31%
CURRENT VS TTM AVG
+4.18%
CURRENT VS 3Y AVG
+2.68%
CURRENT VS 5Y AVG
+1.74%
CURRENT VS 10Y AVG
+2.22%
CURRENT VS 15Y AVG
+3.52%
CURRENT VS 20Y AVG
+3.14%
SECTOR MEDIAN · HEALTHCARE
58.51%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-6.02%
vs the sector median at left
Agilent Technologies, Inc.
Market Cap
$39.14B
Gross Margin
54.99%
TTM Avg
52.78%
3Y Avg
53.55%
5Y Avg
54.05%
Market Cap
$36.28B
Gross Margin
80.89%
TTM Avg
83.69%
3Y Avg
83.53%
5Y Avg
83.62%
Market Cap
$42.94B
Gross Margin
62.05%
TTM Avg
61.42%
3Y Avg
60.55%
5Y Avg
59.83%
Market Cap
$47.58B
Gross Margin
78.01%
TTM Avg
78.79%
3Y Avg
78.80%
5Y Avg
77.78%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agilent Technologies, Inc. (A) | $39.14B | 54.99% | 52.78% | 53.55% | 54.05% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $36.28B | 80.89% | 83.69% | 83.53% | 83.62% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $42.94B | 62.05% | 61.42% | 60.55% | 59.83% |
| IQVIA Holdings Inc. (IQV)vs › | $34.72B | 26.11% | 30.59% | 32.75% | 33.07% |
| Medline Inc. (MDLN)vs › | $32.77B | 24.04% | 25.55% | 23.71% | 23.71% |
| Zoetis Inc. (ZTS)vs › | $31.59B | 70.75% | 69.79% | 68.91% | 68.46% |
| Humana Inc. (HUM)vs › | $46.74B | 14.01% | 14.54% | 16.14% | 17.03% |
| Centene Corp. (CNC)vs › | $31.31B | 14.93% | 11.28% | 11.33% | 11.71% |
| Edwards Lifesciences Corporation (EW)vs › | $47.58B | 78.01% | 78.79% | 78.80% | 77.78% |
| Biogen Inc. (BIIB)vs › | $29.85B | 69.77% | 73.30% | 74.61% | 77.63% |
Gross Margin
55.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-04-30 | 54.99% |
| 2026-01-31 | 52.61% |
| 2025-10-31 | 51.80% |
| 2025-07-31 | 52.59% |
| 2025-04-30 | 51.92% |
| 2025-01-31 | 53.48% |
| 2024-10-31 | 53.85% |
| 2024-07-31 | 54.18% |
| 2024-04-30 | 54.42% |
| 2024-01-31 | 54.76% |
| 2023-10-31 | 54.21% |
| 2023-07-31 | 39.35% |
| 2023-04-30 | 53.81% |
| 2023-01-31 | 55.13% |
| 2022-10-31 | 54.73% |
| 2022-07-31 | 54.66% |
| 2022-04-30 | 53.58% |
| 2022-01-31 | 54.36% |
| 2021-10-31 | 54.22% |
| 2021-07-31 | 53.72% |
| 2021-04-30 | 53.57% |
| 2021-01-31 | 54.13% |
| 2020-10-31 | 53.14% |
| 2020-07-31 | 53.05% |
| 2020-04-30 | 53.07% |
| 2020-01-31 | 53.28% |
| 2019-10-31 | 53.91% |
| 2019-07-31 | 54.32% |
| 2019-04-30 | 54.04% |
| 2019-01-31 | 55.06% |
| 2018-10-31 | 54.79% |
| 2018-07-31 | 54.95% |
| 2018-04-30 | 53.40% |
| 2018-01-31 | 55.57% |
| 2017-10-31 | 54.42% |
| 2017-07-31 | 53.50% |
| 2017-04-30 | 53.72% |
| 2017-01-31 | 53.80% |
| 2016-10-31 | 52.93% |
| 2016-07-31 | 51.92% |
| 2016-04-30 | 52.01% |
| 2016-01-31 | 52.24% |
| 2015-10-31 | 51.69% |
| 2015-07-31 | 50.59% |
| 2015-04-30 | 49.84% |
| 2015-01-31 | 50.00% |
| 2014-10-31 | 45.93% |
| 2014-07-31 | 49.75% |
| 2014-04-30 | 49.09% |
| 2014-01-31 | 50.60% |
| 2013-10-31 | 52.85% |
| 2013-07-31 | 51.82% |
| 2013-04-30 | 51.44% |
| 2013-01-31 | 52.38% |
| 2012-10-31 | 52.18% |
| 2012-07-31 | 51.65% |
| 2012-04-30 | 52.97% |
| 2012-01-31 | 53.46% |
| 2011-10-31 | 53.30% |
| 2011-07-31 | 52.75% |
| 2011-04-30 | 53.67% |
| 2011-01-31 | 53.72% |
| 2010-10-31 | 52.92% |
| 2010-07-31 | 52.38% |
| 2010-04-30 | 55.94% |
| 2010-01-31 | 54.41% |
| 2009-10-31 | 54.33% |
| 2009-07-31 | 50.99% |
| 2009-04-30 | 48.58% |
| 2009-01-31 | 50.51% |
| 2008-10-31 | 56.04% |
| 2008-07-31 | 55.61% |
| 2008-04-30 | 55.43% |
| 2008-01-31 | 54.27% |
| 2007-10-31 | 54.63% |
| 2007-07-31 | 55.17% |
| 2007-04-30 | 55.30% |
| 2007-01-31 | 53.98% |
| 2006-10-31 | 60.56% |
| 2006-07-31 | 54.44% |
| 2006-04-30 | 51.15% |
| 2006-01-31 | 50.82% |
| 2005-10-31 | 205.71% |
| 2005-07-31 | 45.32% |
| 2005-04-30 | 46.80% |
| 2005-01-31 | 45.30% |
| 2004-10-31 | 42.81% |
| 2004-07-31 | 42.23% |
| 2004-04-30 | 44.13% |
| 2004-01-31 | 44.98% |
| 2003-10-31 | 42.45% |
| 2003-07-31 | 36.48% |
| 2003-04-30 | 34.49% |
| 2003-01-31 | 37.46% |
| 2002-10-31 | 35.71% |
| 2002-07-31 | 39.18% |
